1-3 of 3
Jean-Jacques Kiladjian
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia

Eytan M. Stein, Daniel J. DeAngelo, Jörg Chromik, Manik Chatterjee, Sebastian Bauer, Chia-Chi Lin, Cristina Suarez, Filip de Vos, Neeltje Steeghs, Philippe A. Cassier, David Tai, Jean-Jacques Kiladjian, Noboru Yamamoto, Rogier Mous, Jordi Esteve, Hironobu Minami, Stephane Ferretti, Nelson Guerreiro, Christophe Meille, Rajkumar Radhakrishnan, Bernard Pereira, Luisa Mariconti, Ensar Halilovic, Claire Fabre, Cecilia Carpio
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (5): 870–881.
https://doi.org/10.1158/1078-0432.CCR-21-1295
Published: 01 March 2022
View article titled, Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type <em>TP53</em> Solid Tumors and Acute Leukemia
Open the PDF for Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type <em>TP53</em> Solid Tumors and Acute Leukemia in another window
Includes: Supplementary data
Journal Articles

A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors

Luis Teixeira, Jacques Medioni, Julie Garibal, Olivier Adotevi, Ludovic Doucet, Marie-Agnès Dragon Durey, Zineb Ghrieb, Jean-Jacques Kiladjian, Mara Brizard, Caroline Laheurte, Maria Wehbe, Elodie Pliquet, Marie Escande, Rémy Defrance, Stephane Culine, Stephane Oudard, Simon Wain-Hobson, Valérie Doppler, Thierry Huet, Pierre Langlade-Demoyen
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (3): 588–597.
https://doi.org/10.1158/1078-0432.CCR-19-1614
Published: 03 February 2020
View article titled, A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors
Open the PDF for A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors in another window
Includes: Supplementary data
Journal Articles

A Constitutional Activating MET Mutation Makes the Genetic Link between Malignancies and Chronic Inflammatory Diseases

Morad El Bouchtaoui, Marcio Do Cruzeiro, Christophe Leboeuf, Irmine Loisel-Ferreira, Carèle Fedronie, Chrystophe Ferreira, Rachida Ait El Far, Marianne Ziol, Marc Espié, Géraldine Falgarone, Bruno Cassinat, Jean-Jacques Kiladjian, Jean-Paul Feugeas, Anne Janin, Guilhem Bousquet
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (14): 4504–4515.
https://doi.org/10.1158/1078-0432.CCR-18-3261
Published: 15 July 2019
View article titled, A Constitutional Activating <em>MET</em> Mutation Makes the Genetic Link between Malignancies and Chronic Inflammatory Diseases
Open the PDF for A Constitutional Activating <em>MET</em> Mutation Makes the Genetic Link between Malignancies and Chronic Inflammatory Diseases in another window
Includes: Supplementary data